Johnson & Johnson JNJ
NYSE JNJ
$280.18 -0.60 (-0.21%)
As of: Nov 11, 2026 · 3:06 PM EST

Johnson & Johnson (JNJ) Cash from Operations (2009 - 2025)

Updated

Johnson & Johnson's Cash from Operations came in at $7.72 billion for Q3 2026, down 15.8% from $9.17 billion a year earlier and down 10.4% from the prior quarter.

Analysis

Johnson & Johnson (JNJ) Cash from Operations (2009 - 2025) Analysis & Trends

Over the trailing twelve months to Sep 27, 2026, Johnson & Johnson reported Cash from Operations of $26.16 billion, up 8.1% year-over-year; for FY2025, it was $24.53 billion, up 1.1% from FY2024.

  • Cash from Operations has increased in each of the last three years, with a four-year compound annual growth rate of 1.0% (FY2021 to FY2025).
  • Going back by year, Cash from Operations was $24.27 billion in FY2024 (+6.5%), $22.79 billion in FY2023 (+7.5%), $21.19 billion in FY2022 and $23.54 billion in FY2021.
  • The five-year range for quarterly Cash from Operations is $2.51 billion (Q1 2026) to $9.17 billion (Q3 2025).
  • Year-over-year, Cash from Operations increased in four of the last eight quarters, with growth averaging 7.2%.
  • The fastest year-over-year change in Cash from Operations over five years came in Q4 2023 (growth of 123.6%), and the weakest in Q1 2026 (a decline of 39.8%).
  • Business Quant data shows JNJ's Cash from Operations at $8.62 billion (Q2 2026), $2.51 billion (Q1 2026) and $7.31 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Yr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 16.81 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.53 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 19.03 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 16.47 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 19.14 Bn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 14.58 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.96 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 10.02 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.70 Bn
10 Vertex Pharmaceuticals 138.90 Bn 106.64 Bn 2.91 Bn 3.63 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 28, 2025 24.53 Bn
Dec 29, 2024 24.27 Bn
Dec 31, 2023 22.79 Bn
Dec 31, 2022 21.19 Bn
Dec 31, 2021 23.41 Bn
Dec 31, 2020 23.54 Bn
Dec 29, 2019 23.42 Bn
Dec 30, 2018 22.20 Bn
Dec 31, 2017 21.06 Bn
Dec 31, 2016 18.77 Bn
Dec 31, 2015 19.57 Bn
Dec 28, 2014 18.71 Bn
Dec 29, 2013 17.41 Bn
Dec 30, 2012 15.40 Bn
Dec 31, 2011 14.30 Bn
Dec 31, 2010 16.39 Bn
Dec 31, 2009 16.57 Bn
API Access

Johnson & Johnson Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations-annual&ticker=JNJ&period=max&api_key=YOUR_API_KEY